Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roark, Rearden & Hamot Capital Management is a Boston-based investment management firm founded in 1997 by Seth W. Hamot. The firm specializes in value-oriented and event-driven investment strategies, often employing an activist approach to its holdings. While primarily a financial services entity, the firm has been a significant investor in the life sciences and healthcare sectors, managing the Costa Brava Partnership funds which have held major stakes in companies such as Inotiv (a contract research organization) and Bradley Pharmaceuticals. The firm is known for its involvement in corporate turnarounds and distressed debt situations across various industries including biotechnology and information technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roark, Rearden & Hamot.